Japan· JP-1319405G2026
アフリベルセプト（遺伝子組換え）
A medicinal product containing アフリベルセプト（遺伝子組換え）, registered in Japan by バイエル薬品, on the national reimbursement list.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- アフリベルセプト（遺伝子組換え）
- Manufacturer
- バイエル薬品
- Country
- Japan (JP)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
アフリベルセプト（遺伝子組換え） in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandAfivegSTADA Arzneimittel AG
- CzechiaAFIVEGSTADA Arzneimittel AG, Bad Vilbel
- BelgiumAfiveg 40 mg/mlStada Arzneimittel
- SwedenAfiveg 40 mg/ml Injektionsvätska, lösningSTADA Arzneimittel AG
- IcelandAfivegSTADA Arzneimittel AG
- SpainAFQLIR 40 MG/ML SOLUCION INYECTABLE EN JERINGA PRECARGADASandoz Gmbh
- NetherlandsAfiveg 40 mg/ml oplossing voor injectieStada Arzneimittel AG
- IrelandAfiveg 40 mg/mL solution for injectionStada Arzneimittel AG
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- United Kingdom (Northern Ireland) · Vgenfli
- Iceland · Afiveg, Afqlir
- Liechtenstein · Afiveg, Afqlir
- Norway · Afiveg, Afqlir
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/db2981d4-be07-4912-88e9-1828075b2f67 GET /v1/drugs/db2981d4-be07-4912-88e9-1828075b2f67?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "８ｍｇ０．０７ｍＬ１筒",
"marks": null,
"source": "mhlw",
"remarks": null,
"yj_code": "1319405G2026",
"category": "注射薬",
"price_yen": 145718,
"generic_name": "アフリベルセプト（遺伝子組換え）",
"product_name_jp": null,
"therapeutic_class": "1319",
"transitional_expiry": null
}See everything about アフリベルセプト（遺伝子組換え）.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.